AU2022222868B2 - Pharmaceutical composition for treating bone diseases - Google Patents

Pharmaceutical composition for treating bone diseases

Info

Publication number
AU2022222868B2
AU2022222868B2 AU2022222868A AU2022222868A AU2022222868B2 AU 2022222868 B2 AU2022222868 B2 AU 2022222868B2 AU 2022222868 A AU2022222868 A AU 2022222868A AU 2022222868 A AU2022222868 A AU 2022222868A AU 2022222868 B2 AU2022222868 B2 AU 2022222868B2
Authority
AU
Australia
Prior art keywords
cells
mesenchymal stem
subject
stem cells
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2022222868A
Other languages
English (en)
Other versions
AU2022222868A1 (en
Inventor
Yumi IYOKU
Yasuaki Oda
Takashi Suyama
Takeshi TAKETANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purec Co Ltd
Original Assignee
Purec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purec Co Ltd filed Critical Purec Co Ltd
Publication of AU2022222868A1 publication Critical patent/AU2022222868A1/en
Application granted granted Critical
Publication of AU2022222868B2 publication Critical patent/AU2022222868B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2022222868A 2021-02-19 2022-02-18 Pharmaceutical composition for treating bone diseases Active AU2022222868B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021024794 2021-02-19
JP2021-024794 2021-02-19
PCT/JP2022/008103 WO2022177032A1 (ja) 2021-02-19 2022-02-18 骨疾患治療用医薬組成物

Publications (2)

Publication Number Publication Date
AU2022222868A1 AU2022222868A1 (en) 2023-09-07
AU2022222868B2 true AU2022222868B2 (en) 2026-03-19

Family

ID=82930724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022222868A Active AU2022222868B2 (en) 2021-02-19 2022-02-18 Pharmaceutical composition for treating bone diseases

Country Status (7)

Country Link
US (1) US20240316109A1 (https=)
JP (1) JP7636032B2 (https=)
KR (1) KR20230133892A (https=)
AU (1) AU2022222868B2 (https=)
CA (1) CA3211195A1 (https=)
TW (1) TWI859508B (https=)
WO (1) WO2022177032A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6363950U (https=) 1986-06-17 1988-04-27
JP6463029B2 (ja) * 2013-08-02 2019-01-30 有未 伊谷 ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法
WO2016017795A1 (ja) 2014-08-01 2016-02-04 有未 伊谷 ヒト間葉系幹細胞の品質評価方法、及び、そのためのモノクローナル抗体
WO2021144995A1 (ja) * 2020-01-16 2021-07-22 ＰｕＲＥＣ株式会社 高純度間葉系幹細胞

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TAKETANI TAKESHI, ET AL., CELL TRANSPLANTATION, SAGE, US, vol. 24, no. 10, 1 October 2015 (2015-10-01), US , pages 1931 - 1943, DOI: 10.3727/096368914X685410 *
YO MABUCHI, EL AL., STEM CELL REPORTS, CELL PRESS, UNITED STATES, vol. 1, no. 2, 6 August 2013 (2013-08-06), United States , pages 152 - 165, DOI: 10.1016/j.stemcr.2013.06.001 *

Also Published As

Publication number Publication date
KR20230133892A (ko) 2023-09-19
JP7636032B2 (ja) 2025-02-26
AU2022222868A1 (en) 2023-09-07
CA3211195A1 (en) 2022-08-25
JPWO2022177032A1 (https=) 2022-08-25
US20240316109A1 (en) 2024-09-26
WO2022177032A1 (ja) 2022-08-25
TWI859508B (zh) 2024-10-21
TW202302123A (zh) 2023-01-16

Similar Documents

Publication Publication Date Title
US8986744B2 (en) Stem cell populations and methods of use
EP2729562B1 (en) Progenitor cells of mesodermal lineage
JP2018121650A (ja) 個の医療のための幹細胞バンク
CN101848991A (zh) 分离的细胞群
WO2009152187A1 (en) Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucoslytransferase
US20170058261A1 (en) Augmentation of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase
KR20170010894A (ko) 림프구로부터의 다계열 분화능 세포 생성 방법
CN108486050B (zh) 从犬的脐带制备间充质干细胞的方法
Lee et al. Role of IGF1R+ MSCs in modulating neuroplasticity via CXCR4 cross-interaction
Chopra et al. Lapine periodontal ligament stem cells for musculoskeletal research in preclinical animal trials
US20080075698A1 (en) Brain-Localizing Bone Marrow Progenitor cells
EP3712256A1 (en) Cell populations comprising cd31-positive, cd45-negative, cd200-positive mammalian cells, and use thereof
JP2005526482A (ja) Ｖｅｇｆｒ−１を発現する幹細胞の単離および動員
AU2022222868B2 (en) Pharmaceutical composition for treating bone diseases
CN103585179A (zh) 一种药物组合物及其在制备治疗骨髓造血功能障碍疾病的药物中的应用
US20150353897A1 (en) Method of generating multilineage potential cells
US20070243171A1 (en) Biological Cell Culture, Cell Culture Media and Therapeutic Use of Biological Cells
JP7003283B2 (ja) 末梢血から間葉系幹細胞集団を製造する方法及びその使用
Skurikhin et al. Anti-fibrotic Effect of Reserpine on Lung Fibrosis: Stem Cells in the Pathogenesis of Pneumofibrosis
Pasha When Problems Become Solutions: Harnessing the Osteogenic Capacity of Disease-Causing Stem Cells to Repair Bone Fractures
US20220370478A1 (en) Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same
AU2024354572A1 (en) Composition for treating and/or preventing mitochondrial disease including high-purity mesenchymal stem cells
WO2025075154A1 (ja) 高純度間葉系幹細胞を含む、ミトコンドリア病を治療及び／又は予防するための組成物
CN121943966A (zh) 人胎盘来源内皮祖细胞和其联合药物及其在制备治疗辐射性胸腺损伤药物中的应用
Lim et al. Delineation of niches which support hematopoiesis